volition.com
Get leads like Volition — and thousands more
Build targeted lists by tech stack, traffic, and more
Volition: The Epigenetic Bet on Early Cancer
A 105-person team betting $27M on nucleosome quantification to catch cancer early.
Most biotech startups chase the latest CRISPR or mRNA craze. Volition is digging deeper—literally—into the epigenetic code of our DNA. By quantifying nucleosomes, they aren't just diagnosing diseases; they are trying to rewrite the timeline of human survival.
"Volition isn't just monitoring disease; they are decoding the biological whispers before the body starts screaming."
The Epigenetic Edge
While the rest of the diagnostics market fights over genetic sequencing (DNA), Volition pivoted to epigenetics (DNA modifications). Their proprietary MENAC platform focuses on nucleosome modifications associated with cancer. This isn't just a scientific nuance; it's a strategic moat. By targeting the 'software' of the genome rather than the 'hardware,' they unlock a layer of biological data that traditional biopsies often miss.
The Revenue vs. Reach Paradox
Here is the reality check for investors: Volition generates $14.9M in revenue with a modest team of 105, yet their web traffic is surprisingly low (12,218 monthly visits). The traffic profile is erratic—undefined regions dominate 83% of their top markets. This suggests a B2B or clinical channel strategy that relies heavily on direct relationships and medical conferences rather than digital inbound marketing. They are selling to labs and hospitals, not consumers.
The brand's digital footprint is telling. With 49% direct traffic and only 35% organic search, Volition operates like a legacy enterprise rather than a modern D2C health brand. Their tech stack—jQuery, Bootstrap, Core-js—feels dated for a company 'driving the future of epigenetics.' It signals that product R&D is prioritized over UX polish. For founders, this is a lesson: sometimes, you build the science first and the website later.
- The 'Volition' brand is powerful but crowded: 'volition' sees 50k+ monthly searches, diluting their specific medical brand awareness.
- Nucleosome Quantification: Their core IP is the ability to isolate and quantify these specific DNA-protein complexes.
- MENAC Platform: A distinct cancer-focused assay that differentiates them from general epigenetic players.
The Quiet Giant of Epigenetics
Volition is a B2B science play, not a consumer app. Ignore the web traffic; watch the clinical data and the $27M war chest.
What tech stack does Volition use?
How much traffic does Volition get?
Traffic & Engagement
Traffic Sources
Where is Volition's audience located?
What keywords does Volition rank for?
5 keywordsHow is Volition's SEO?
Open Graph Image
https://volition.com/wp-content/uploads/2023/10/volition-early-diagnosis.jpg
Meta Tags
Volition - Early Diagnosis and Nucleosome Quantification
Revolutionizing early diagnosis and monitoring of life-altering diseases. Driving the future of epigenetics through nucleosome quantification.
Home
H1 Tags
Schema Types
What is Volition's revenue?
Who works at Volition?
Loading leads...
What do customers think of Volition?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Volition
What is Volition's Revenue?
What does Volition do?
How fast is Volition growing?
What technologies does Volition use?
Who are Volition's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Volition?
Contact Information
Export volition.com Data
Download the complete tech stack, analytics, leads, and company data for volition.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About volition.com
Revolutionizing early diagnosis and monitoring of life-altering diseases. Driving the future of epigenetics through nucleosome quantification.
Company Overview
volition.com Social Media
Contact volition.com
Phone Numbers
Technology Stack
volition.com uses 16 technologies across their website including reCAPTCHA, PHP, WordPress, and more.
Security
reCAPTCHA
Programming Languages
PHP
CMS
WordPress
Cloud & Hosting
Cloudflare
Privacy & Consent
CookieYes
Advertising
DoubleClick Floodlight
Traffic & Audience
volition.com receives approximately 12.2K monthly visitors and ranks #1,894,073 globally. The website has a bounce rate of 41% with visitors viewing an average of 1.9 pages per visit. Users spend an average of 0:57 on the site.
The majority of volition.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is volition.com?
What technologies does volition.com use?
How do I contact volition.com?
What are volition.com's social media accounts?
Is volition.com hiring?
How popular is volition.com?
Related Searches
This page provides publicly available information about volition.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit volition.com directly at https://volition.com.